WebMD reports higher ad revenues, site traffic

Share this article:
Higher ad revenues and traffic to WebMD's physician and consumer web portals boosted second-quarter earnings, the healthcare information firm said.

Ad revenue jumped 32% during the April-June period, vs. the same period last year, to $100.6 million from $76 million. Traffic to the WebMD Health Network reached an average of 80.7 million unique users per month and total traffic of 1.8 billion page views during the quarter, increases of 35% and 22%, respectively, from a year ago. On the WebMD Professional Network, 1.5 million CME programs were completed.

That helped the firm swing to a second-quarter profit with earnings of $7.68 million, or 13 cents a share, compared with a loss of $11.7 million, or 25 cents, in the year-earlier quarter.

WebMD does not break down physician and consumer ad revenues, but a source told MM&M that revenue contributions from the two are roughly equal. Physician portal ad sales are derived almost exclusively from the pharmaceutical industry, the source said, while consumer portal sales come mostly from pharma with a growing portion from consumer packaged goods companies.
Share this article:

Email Newsletters

More in News

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.

GSK, Novartis, Lilly play musical chairs

GSK, Novartis, Lilly play musical chairs

The three drugmakers rearranged part of the pharma universe Tuesday with a string of pipeline-altering deals.

Valeant bids $47B for Allergan

Valeant bids $47B for Allergan

The deal would bring Allergan's Botox and Juvederm under the same roof as Restylane.